Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis.
about
Gout increases risk of fracture: A nationwide population-based cohort study.Effects of High and Low Doses of Folic Acid on the Soluble Receptor Activator of Nuclear Factor-kappa B Ligand/Osteoprotegerin Ratio during Pregnancy.Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases.Maternal plasma osteoprotegerin concentration in normal pregnancyFGF-23, α-Klotho Gene Polymorphism and Their Relationship with the Markers of Bone Metabolism in Chronic Peritoneal Dialysis PatientsNew and improved glucocorticoid receptor ligands.Vascular calcification and renal osteodystrophy relationship in chronic kidney disease.An experimental study to evaluate the antiosteoporotic effect of Panchatikta Ghrita in a steroid-induced osteoporosis rat model.Therapeutic implications of osteoprotegerin.Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.Multiparameter Analysis of Off-Target Effects of Dasatinib on Bone Homeostasis in Patients With Newly Diagnosed Chronic Myelogenous Leukemia.Markers of bone remodeling are associated with arterial stiffness in renal transplanted subjects.Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes.Factors other than glucocorticoids are involved in the osteoblast activity decrease caused by tissue injury.Low Doses of Simvastatin Potentiate the Effect of Sodium Alendronate in Inhibiting Bone Resorption and Restore Microstructural and Mechanical Bone Properties in Glucocorticoid-Induced Osteoporosis.Osteoprotegerin and Cardiovascular Events in High-Risk Populations: Meta-Analysis of 19 Prospective Studies Involving 27 450 Participants
P2860
Q33590612-15D8B2CD-23E2-4938-AD4C-44ED0E43D8BAQ33711088-23F923F7-9F10-40A7-816C-FFA1DBD66A5DQ34086847-E1CD6C4C-A2DA-47BF-BFDB-202304C52669Q34313689-50B74F46-074E-417E-BB41-476533D7D90EQ35827508-50A20647-3F2A-417E-9DDA-D1665DB70453Q36322079-2C6E3724-426A-4AD0-92E2-6921D8081CF0Q36554786-D3C823E8-F627-41F0-9041-6FE8DC94BD84Q36986824-33C27931-4D0E-4F88-A1C1-2372138BA1CCQ37368570-9688D830-F550-486C-91F6-C4A0EE192DFEQ39177137-A2C59E6B-C3F7-4D05-BCA8-127F4CF9912FQ40397359-C4343349-FC33-48F8-9B1D-DD0909B7CE99Q41003926-E434548F-6C5C-4717-8B1D-51F575A91F93Q45797594-220AE79E-733B-43E0-9AC8-B2630D6C8459Q46951286-7330711D-CF36-452F-AC17-7C87F1F6612BQ48029073-0274C2E8-E411-454E-B199-085A559EE9C9Q58129712-E53FCCE5-CE6F-4A16-8504-586F4CEADBFF
P2860
Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Glucocorticoid decreases circu ...... orticoid induced osteoporosis.
@ast
Glucocorticoid decreases circu ...... orticoid induced osteoporosis.
@en
type
label
Glucocorticoid decreases circu ...... orticoid induced osteoporosis.
@ast
Glucocorticoid decreases circu ...... orticoid induced osteoporosis.
@en
prefLabel
Glucocorticoid decreases circu ...... orticoid induced osteoporosis.
@ast
Glucocorticoid decreases circu ...... orticoid induced osteoporosis.
@en
P2093
P356
P1476
Glucocorticoid decreases circu ...... orticoid induced osteoporosis.
@en
P2093
P304
P356
10.1093/NDT/16.3.479
P407
P577
2001-03-01T00:00:00Z